EULAV Asset Management’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-56,400
Closed -$3.91M 307
2017
Q1
$3.91M Sell
56,400
-70,700
-56% -$4.91M 0.2% 157
2016
Q4
$8.47M Sell
127,100
-68,300
-35% -$4.44M 0.46% 72
2016
Q3
$12.9M Sell
195,400
-17,200
-8% -$1.18M 0.69% 43
2016
Q2
$15.4M Hold
212,600
0.85% 37
2016
Q1
$13.7M Buy
212,600
+6,000
+3% +$398K 0.77% 40
2015
Q4
$14.8M Hold
206,600
0.81% 33
2015
Q3
$15.9M Hold
206,600
0.9% 25
2015
Q2
$15.3M Buy
206,600
+9,200
+5% +$662K 0.8% 25
2015
Q1
$14.3M Buy
197,400
+11,600
+6% +$806K 0.74% 29
2014
Q4
$12.3M Buy
185,800
+34,400
+23% +$2.1M 0.66% 40
2014
Q3
$8.3M Buy
151,400
+11,200
+8% +$635K 0.45% 87
2014
Q2
$8.15M Buy
140,200
+10,000
+8% +$588K 0.44% 84
2014
Q1
$8.07M Hold
130,200
0.44% 86
2013
Q4
$6.95M Buy
130,200
+10,000
+8% +$537K 0.38% 95
2013
Q3
$6.03M Buy
120,200
+8,000
+7% +$390K 0.35% 99
2013
Q2
$5.14M Buy
+112,200
New +$5.02M 0.31% 112

Other funds holding MD

EULAV Asset Management's MD Position: Q2 2017 in Review

EULAV Asset Management sold out of Pediatrix Medical (MD) in Q2 2017, closing a stake of 56,400 shares — an estimated $3.91M sold.

EULAV Asset Management first reported a position in MD in Q2 2013 and held it in 16 quarters. The position peaked at $15.9M in Q3 2015. 332 funds tracked by Wall St. Rank hold MD as of Q2 2017.

  • EULAV Asset Management reported no remaining Pediatrix Medical position as of Q2 2017 after selling out during the quarter.
  • EULAV Asset Management sold 56,400 Pediatrix Medical shares in Q2 2017, an estimated $3.91M.
  • EULAV Asset Management first reported a position in Pediatrix Medical in Q2 2013 and held it in 16 quarters.
  • EULAV Asset Management's Pediatrix Medical position peaked at $15.9M in Q3 2015.
  • 332 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2017.

Based on EULAV Asset Management's 13F filing for Q2 2017, filed 14 Aug 2017.